Next Article in Journal
Long Non-Coding RNAs in Endometrial Carcinoma
Previous Article in Journal
Alzheimer’s Disease: Mechanism and Approach to Cell Therapy
Article Menu
Issue 11 (November) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2015, 16(11), 26452-26462; doi:10.3390/ijms161125968

The Estrogen Receptor-β Expression in De Quervain’s Disease

1
Department of Orthopedics, Tainan Hospital, Ministry of Health and Welfare, Tainan 70043, Taiwan
2
Department of Orthopedics, Chi-Mei Medical Center, Tainan 71004, Taiwan
3
Department of Orthopedics, National Cheng Kung University College of Medicine, 1 Dashuei Road, Tainan 70101, Taiwan
4
Department of Orthopedics, Kuo’s General Hospital, Tainan 70054, Taiwan
5
Department of Nursing, Chung Hwa University of Medical Technology, 89 Wenhua 1st Street, Rende District, Tainan 71703, Taiwan
*
Authors to whom correspondence should be addressed.
Academic Editor: Kurt A. Jellinger
Received: 3 September 2015 / Revised: 22 October 2015 / Accepted: 29 October 2015 / Published: 4 November 2015
(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
View Full-Text   |   Download PDF [4595 KB, uploaded 4 November 2015]   |  

Abstract

Stenosing tenosynovitis of the first dorsal compartment of the wrist (a.k.a. de Quervain’s disease) is common but how estrogen is involved is still unknown. We previously reported that inflammation was involved in the pathogenesis of this ailment. In the present study, we extended our investigation of estrogen receptor (ER)-β expression to determine whether estrogen is involved in the pathogenesis of de Quervain’s. Intraoperative retinaculum samples were collected from 16 patients with the ailment. Specimens were histologically graded by collagen structure and immunohistochemically evaluated by quantifying the expression of ER-β, interleukin (IL)-1β and IL-6 (inflammatory cytokines), cyclooxygenase (COX)-2 (an inflammatory enzyme), and vascular endothelial growth factor (VEGF), and Von Willebrand’s factor (vWF). De Quervain’s occurs primarily in women. The female:male ratio in our study was 7:1. We found that ER-β expression in the retinaculum was positively correlated with disease grade and patient age. Additionally, disease severity was associated with inflammatory factors—IL-1β and IL-6, COX-2, and VEGF and vWF in tenosynovial tissue. The greater the levels of ER-β expression, tissue inflammation, and angiogenesis are, the more severe de Quervain’s disease is. ER-β might be a useful target for novel de Quervain’s disease therapy. View Full-Text
Keywords: estrogen receptor-β; de Quervain’s disease; inflammation; angiogenesis estrogen receptor-β; de Quervain’s disease; inflammation; angiogenesis
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Shen, P.-C.; Wang, P.-H.; Wu, P.-T.; Wu, K.-C.; Hsieh, J.-L.; Jou, I.-M. The Estrogen Receptor-β Expression in De Quervain’s Disease. Int. J. Mol. Sci. 2015, 16, 26452-26462.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top